Clinical Trial Update: Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer [NA]

View source ↗

Summary

Clinical trial investigating preoperative sintilimab with bevacizumab and chemotherapy for resectable non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Chemotherapy (unspecified regimen)
• Tyvyt (Sintilimab) (Sintilimab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Lung Neoplasm Malignant | NA | Status: RECRUITING